Accelerator incubator raises $23M for new biotech investments
Accelerator, a Seattle biotech incubator linked to the Institute for Systems Biology, raised $22.5 million in a third funding round. The round was led by Amgen Ventures, Arch Venture Partners and OVP Venture Partners, joined by Alexandria Real Estate Equities and WRF Capital.
Accelerator has so far arranged funding for and managed six biotech startups, of which two — VLST and Spaltudaq — have moved on from the incubator, between them raising another $84 million in follow-on financing.
Next Story: EzRez raises $15M more for travel site customization
Previous Story: KineMed pulls in $15M for Lou Gehrig's disease
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.
